ME

Medipost​‍‌‍‍‍‌​‍‌‌‌​‌​‌‌​‍‌‍‍‌​‍​

company active
Biotech firm jointly acquired by Crescendo and Skylake
Tracked:Biotech firm jointly acquired by Crescendo and Skylake · 2 documented connections
2
Facts
2
Connections
7
Sources
View on Graph → Export CSV ← Entity Directory
Connection Map
Key Connections
← Crescendo Equity Partners company
portfolio_investment
Recent investment in January 2026
← Crescendo Equity Partners company
investment
Most recent investment made on January 9, 2026
Facts (2)
Data Freshness
Fresh Last update: 0d ago · Avg age: 1218d
Confidence Tiers: Primary Source — cross-referenced government/corporate filings Pending Review — sourced but not independently verified AI Inference — analytical hypothesis from cross-referencing
Documented Records (1)
Sourced from government databases, press reports, and corporate filings. Not yet independently verified.
Primary Source Medipost filed filing with the SEC o​‍‌‍‍‍‌​‍‌‌‌​‌​‌‌​‍‌‍‍‌​‍​n 2021-02-03. Accession number: N/A.
Raw Filing Records (1) — unsourced metadata
Pending Review Medipost filed filing with the SEC o​‍‌‍‍‍‌​‍‌‌‌​‌​‌‌​‍‌‍‍‌​‍​n 2024-03-11. Accession number: N/A.
Date: 2024-03-11 Added: 09 Apr 2026 SEC FILING SEC EDGAR: filing — Medipost (2024-03-11) 📋
All Connections (2)
portfolio_investment confirmed
Recent investment in January 2026
investment confirmed
Most recent investment made on January 9, 2026
Sources (7)
2021-02-03 ↗ SEC EDGAR: filing — Medipost (2021-02-03) sec_filing Processed
2021-02-08 SEC FILING SEC EDGAR: filing — Medipost (2021-02-08) sec_filing Processed
2021-01-19 SEC FILING SEC EDGAR: filing — Medipost (2021-01-19) sec_filing Processed
2021-03-30 SEC FILING SEC EDGAR: filing — Medipost (2021-03-30) sec_filing Processed
2022-03-11 SEC FILING SEC EDGAR: filing — Medipost (2022-03-11) sec_filing Processed
2023-03-14 SEC FILING SEC EDGAR: filing — Medipost (2023-03-14) sec_filing Processed
2024-03-11 SEC FILING SEC EDGAR: filing — Medipost (2024-03-11) sec_filing Processed